[go: up one dir, main page]

NO20061033L - Sammensetninger og fremgangsmater for levering av biologiske aktive midler - Google Patents

Sammensetninger og fremgangsmater for levering av biologiske aktive midler

Info

Publication number
NO20061033L
NO20061033L NO20061033A NO20061033A NO20061033L NO 20061033 L NO20061033 L NO 20061033L NO 20061033 A NO20061033 A NO 20061033A NO 20061033 A NO20061033 A NO 20061033A NO 20061033 L NO20061033 L NO 20061033L
Authority
NO
Norway
Prior art keywords
compositions
biologically active
delivery
methods
active agents
Prior art date
Application number
NO20061033A
Other languages
English (en)
Inventor
Russell John Tait
Benjamin James Boyd
Gregory Andrew Davey
Annette Joan Murphy
Darryl Vanstone Whittaker
Shui-Mei Khoo
Calum John Drummond
Original Assignee
Mayne Pharma Int Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2003904717A external-priority patent/AU2003904717A0/en
Application filed by Mayne Pharma Int Pty Ltd filed Critical Mayne Pharma Int Pty Ltd
Publication of NO20061033L publication Critical patent/NO20061033L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer fremgangsmåter og sammensetninger for avgivelse av et biologisk aktivt middel til et biologisk system. Sammensetningene innbefatter det aktive middel og en lyotropisk fase, og frigjøring av det aktive middel til det biologiske system modifiseres ved den lyotropiske fase.
NO20061033A 2003-09-01 2006-03-02 Sammensetninger og fremgangsmater for levering av biologiske aktive midler NO20061033L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2003904717A AU2003904717A0 (en) 2003-09-01 Oral drug delivery systems
AU2003904719A AU2003904719A0 (en) 2003-09-01 Compositions for delivery of biologically active agents
PCT/AU2004/001181 WO2005021046A1 (en) 2003-09-01 2004-09-01 Compositions and methods for delivery of biologically active agents

Publications (1)

Publication Number Publication Date
NO20061033L true NO20061033L (no) 2006-05-22

Family

ID=34275844

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061033A NO20061033L (no) 2003-09-01 2006-03-02 Sammensetninger og fremgangsmater for levering av biologiske aktive midler

Country Status (6)

Country Link
US (1) US20070108405A1 (no)
EP (1) EP1667656A4 (no)
JP (1) JP2007504256A (no)
CA (1) CA2546482A1 (no)
NO (1) NO20061033L (no)
WO (1) WO2005021046A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002951216A0 (en) * 2002-09-05 2002-09-19 Dbl Australia Pty Ltd Surfactants and lyotropic phases formed therefrom
WO2006043705A1 (ja) * 2004-10-19 2006-04-27 National Institute Of Advanced Industrial Scienceand Technology Ｉｉ型キュービック液晶組成物
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
WO2007140510A1 (en) * 2006-06-02 2007-12-13 Monash University Agrochemical composition comprising liquid crystal particles
ES2851177T3 (es) * 2007-04-11 2021-09-03 Biomarin Pharm Inc Tetrahidrobiopterina para el tratamiento de afecciones asociadas con niveles elevados de fenilalanina
JP5599705B2 (ja) 2007-05-18 2014-10-01 デュレクト コーポレーション 改良されたデポー製剤
WO2008153611A2 (en) 2007-05-25 2008-12-18 Qlt Usa, Inc. Sustained delivery formulations of risperidone compounds
WO2010063080A1 (en) 2008-12-05 2010-06-10 Commonwealth Scientific And Industrial Research Organisation Amphiphile prodrugs
US9125805B2 (en) 2012-06-27 2015-09-08 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of small molecule drugs
KR101601035B1 (ko) * 2013-02-28 2016-03-08 주식회사 종근당 키토산 및 액상결정 형성 물질을 포함하는 유전자 전달용 조성물
US20140308352A1 (en) 2013-03-11 2014-10-16 Zogenix Inc. Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
CN115804749A (zh) 2013-03-11 2023-03-17 度瑞公司 包含高粘度液体载体的可注射控制释放组合物
KR102537085B1 (ko) * 2014-01-17 2023-05-25 옹코랄 파르마 에이피에스 암의 치료를 위한 이리노테칸의 고형 경구 투여형
EP4378463A3 (en) 2017-06-02 2024-10-23 Xeris Pharmaceuticals, Inc. Precipitation resistant small molecule drug formulations

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3677726A (en) * 1970-08-03 1972-07-18 Monsanto Co Monosubstituted ureas as fuel additives
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
JPS59101448A (ja) * 1982-11-30 1984-06-12 Eisai Co Ltd ポリプレニルカルボン酸アミドおよびその製造方法ならびにそれを含有する医薬
CA1264162A (en) * 1984-03-15 1990-01-02 Manfred Breuninger Glycerol ether phosphatides
CA2120359C (en) * 1991-10-04 2000-12-26 Tomas Landh Particles, method of preparing said particles and uses thereof
FR2720937B1 (fr) * 1994-06-08 1997-03-28 Oreal Composition cosmétique ou dermatologique sous forme de dispersion, aqueuse et stable, de particules de gel cubique à base de phytantriol et contenant un agent tensioactif à chaîne grasse en tant qu'agent dispersant et stabilisant.
DE4420625C1 (de) * 1994-06-14 1995-11-02 Beiersdorf Ag Wirkstoffkombination mit einem Gehalt an Glycerylalkylethern und kosmetische und dermatologische Zubereitungen, solche Wirkstoffkombinationen enthaltend
FR2726762B1 (fr) * 1994-11-10 1997-01-17 Oreal Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse dans une phase aqueuse stabilisee a l'aide de particules de gel cubique et son procede d'obtention
EP0871489A1 (en) * 1995-10-12 1998-10-21 Gs Development Ab A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface
FR2750334B1 (fr) * 1996-07-01 1998-09-04 Oreal Utilisation de derives amino-alcools a fonction uree dans et pour la preparation de compositions cosmetiques ou dermatologiques
JP2001524958A (ja) * 1997-04-17 2001-12-04 ジーエス ディベロップメント アクティエボラーグ 新規な液晶をベースとする生物接着性薬剤送出系
EP1138313A1 (de) * 2000-03-28 2001-10-04 Primacare S.A. Pro-liposomen
FR2809957B1 (fr) * 2000-06-08 2002-10-04 Oreal Utilisation de particules de gel cubique comme agent anti-pollution, notamment dans une composition cosmetique
US20020153508A1 (en) * 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
DE60140815D1 (de) * 2000-10-12 2010-01-28 Kao Corp Mittel zur verkleinerung der hautporen und zur verbesserung der hautelastizität
US7008646B2 (en) * 2001-02-20 2006-03-07 Patrick Thomas Spicer Cubic liquid crystalline compositions and methods for their preparation
US7129275B2 (en) * 2001-10-31 2006-10-31 Coreana Cosmetics Co., Ltd. Compositions for treating acne comprising phytandiol amine
AU2002951216A0 (en) * 2002-09-05 2002-09-19 Dbl Australia Pty Ltd Surfactants and lyotropic phases formed therefrom

Also Published As

Publication number Publication date
US20070108405A1 (en) 2007-05-17
EP1667656A1 (en) 2006-06-14
JP2007504256A (ja) 2007-03-01
CA2546482A1 (en) 2005-03-10
EP1667656A4 (en) 2011-12-28
WO2005021046A1 (en) 2005-03-10

Similar Documents

Publication Publication Date Title
NO20061033L (no) Sammensetninger og fremgangsmater for levering av biologiske aktive midler
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
MY142589A (en) Benzimidazole derivatives : preparation and pharmaceutical applications
EA200870599A1 (ru) Стабильные препараты лаквинимода
NO20055863L (no) W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
EA200802213A1 (ru) Способы лечения заболеваний крови
TW200716647A (en) Synthesis of (R)-N-methylnaltrexone
ATE433447T1 (de) Pyrimiidinverbindungen
TNSN07161A1 (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
EA200602196A1 (ru) Производные пиразола, композиции, содержащие эти соединения, и способы применения
UA94749C2 (en) Benzimidazole modulators of vr1
TW200833370A (en) Pharmaceutical composition containing low substituted hydroxypropylcellulose
CL2007000789A1 (es) Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer.
MA31567B1 (fr) Derives de 7 -alkynyl-1.8-naphthyrid0nes, leur preparation et leur application en therapeutique
MX2007004765A (es) Compuestos y metodos que modulan la actividad de la trombopoyetina.
NO20062739L (no) Kontrollert frigivining av topirimat i flytende doseringsform
UA96277C2 (en) Benzimidazole derivatives
GB2446341A (en) Method and system for transdermal drug delivery
SE0402284D0 (sv) New heterocyclic amides
CY1110156T1 (el) Υποκατεστημενες ενωσεις 4,5,6,7-τετραϋδρο-βενζοθειαζολ-2-υλαμινης
NO20065898L (no) 1-heterocyklyl-1,5-dihydro-pyrido[3,2-b]indol-2-oner
NO20062022L (no) 1-(kinolinamino)- og 1-(isokinolinamino)-substituerte pentan-2-oler, fremgangsmate for fremstilling av disse og anvendelse av den som antiinflammatoriske midler
EA200401462A1 (ru) Однокамерная система осмотически регулируемой доставки лекарственного средства
TW200738244A (en) 20-Alkyl, gemini vitamin D3 compounds and methods of use thereof
EA200970368A1 (ru) Новый кристалл (s)-(+)-2-(2-хлорфенил)-2-гидроксиэтилкарбамата

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application